awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q37311579-30CB8772-DCFE-4A67-831A-92F6769D35F6
Q37311579-30CB8772-DCFE-4A67-831A-92F6769D35F6
BestRank
Statement
http://www.wikidata.org/entity/statement/Q37311579-30CB8772-DCFE-4A67-831A-92F6769D35F6
Safety, pharmacokinetics, and antitumor properties of anlotinib, an oral multi-target tyrosine kinase inhibitor, in patients with advanced refractory solid tumors
P2860
Q37311579-30CB8772-DCFE-4A67-831A-92F6769D35F6
BestRank
Statement
http://www.wikidata.org/entity/statement/Q37311579-30CB8772-DCFE-4A67-831A-92F6769D35F6
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
7f266f9151dc36e1387b3b632a6a8805c1ac5115
P2860
Combined inhibition of DDR1 and Notch signaling is a therapeutic strategy for KRAS-driven lung adenocarcinoma.